Quantcast
Last updated on April 18, 2014 at 9:36 EDT

Interventional Radiology and Cardiology Treatment Methods Find Newer Markets in Asia-Pacific, Finds Frost & Sullivan

March 26, 2013

Benefits such as lower in-patient admission rates and faster recovery times boost adoption

KUALA LUMPUR, Malaysia, March 26, 2013 /PRNewswire/ — The growing number of aging people, along with the high incidence of cardiovascular and cerebrovascular diseases in Asia-Pacific due to unhealthy lifestyles, has spurred the need for interventional radiology and cardiology procedures. Interventional methods’ benefits such as reduced hospitalization and faster recovery times have lowered in-patient admission rates and lent momentum to the market in the region.

New analysis from Frost & Sullivan (http://www.medtech.frost.com), Asia-Pacific Interventional Radiology and Cardiology Market Assessment, finds that the market earned revenues of more than US$591.3 million in 2012 and estimates this to grow at a CAGR of 3.5 % through 2017.

Greater focus on the early diagnosis and treatment of diseases, and government initiatives to promote health check-up programs, aid the growth of the interventional radiology and cardiology market in Asia-Pacific.

“Asia-Pacific’s modern infrastructure, sophisticated technology, international accreditation, and cost advantages have made the region a hot-spot for foreign travelers seeking medical care,” said Frost & Sullivan Healthcare Consultant Poornima Srinivasan. “The rising influx of medical tourists for the diagnosis and treatment of cardiovascular, neurological and vascular disorders drive demand for minimally invasive procedures in radiology and cardiology.”

Although most countries in the Asia-Pacific position themselves as ideal destinations for medical tourism, the limited budgets of hospitals and medical facilities curb their ability to offer interventional therapies. Public sector hospitals are reluctant to invest in interventional treatment systems owing to high equipment costs and a shortage in workforce and infrastructure.

To equip healthcare centers, governments in the region are chalking out strategies for increased funding and setting up educational institutions to train specialists. Equipment vendors too are providing new private hospitals in developing countries with integrated solutions to enhance penetration while universities and private hospitals in developed Asia-Pacific countries are looking to establish hybrid labs to enhance co-ordinated care for endovascular procedures in an interventional environment.

“Multinational manufacturers must partner with local vendors to build integrated networks and pave the way for market expansion,” concluded Srinivasan. “The development of innovative, competitively-priced solutions and robust after-sales services is crucial to ensure that interventional radiology and cardiology technologies in Asia-Pacific are on par with developed countries.”

If you are interested in more information on this research, please send an email to Donna Jeremiah, Corporate Communications, at djeremiah@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

Asia-Pacific Interventional Radiology and Cardiology Market Assessment is part of the Advanced Medical Technologies Growth Partnership Service program. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion

Join Us: Join our community

Subscribe: Newsletter on “the next big thing”

Register: Gain access to visionary innovation

Asia-Pacific Interventional Radiology and Cardiology Market Assessment
P711-54

Contact:
Donna Jeremiah
Corporate Communications – Asia Pacific
P: +61 (02) 8247 8927
F: +61 (02) 9252 8066
E: djeremiah@frost.com

Carrie Low
Corporate Communications – Asia Pacific
P: +603 6204 5910
F: +603 6201 7402
E: carrie.low@frost.com

Jessie Loh
Corporate Communications – Asia Pacific
P: +65 6890 0942
F: +65 6890 0988
E: jessie.loh@frost.com

http://www.frost.com

SOURCE Frost & Sullivan


Source: PR Newswire